Templeton & Phillips Capital Management LLC Has $1.21 Million Stake in HCA Healthcare, Inc. (NYSE:HCA)

Templeton & Phillips Capital Management LLC reduced its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 2.4% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 4,040 shares of the company’s stock after selling 98 shares during the quarter. HCA Healthcare accounts for approximately 1.0% of Templeton & Phillips Capital Management LLC’s portfolio, making the stock its 21st largest position. Templeton & Phillips Capital Management LLC’s holdings in HCA Healthcare were worth $1,213,000 at the end of the most recent reporting period.

Other large investors have also bought and sold shares of the company. Legacy Investment Solutions LLC acquired a new position in HCA Healthcare in the third quarter valued at approximately $39,000. Whipplewood Advisors LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $31,000. Tidemark LLC acquired a new stake in HCA Healthcare in the fourth quarter worth $36,000. Activest Wealth Management raised its holdings in shares of HCA Healthcare by 1,250.0% during the fourth quarter. Activest Wealth Management now owns 135 shares of the company’s stock worth $40,000 after acquiring an additional 125 shares during the period. Finally, Pinnacle Bancorp Inc. increased its stake in HCA Healthcare by 50.0% in the 4th quarter. Pinnacle Bancorp Inc. now owns 150 shares of the company’s stock valued at $45,000 after buying an additional 50 shares during the last quarter. 62.73% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research analysts have recently commented on HCA shares. Cantor Fitzgerald reissued an “overweight” rating and issued a $405.00 price objective on shares of HCA Healthcare in a research report on Monday, January 27th. KeyCorp dropped their target price on shares of HCA Healthcare from $420.00 to $370.00 and set an “overweight” rating for the company in a research report on Tuesday, January 7th. Barclays lowered their price objective on shares of HCA Healthcare from $392.00 to $366.00 and set an “overweight” rating for the company in a research report on Monday, January 27th. Truist Financial lowered their price objective on shares of HCA Healthcare from $430.00 to $390.00 and set a “buy” rating for the company in a research report on Monday, January 6th. Finally, Royal Bank of Canada reduced their target price on shares of HCA Healthcare from $405.00 to $384.00 and set an “outperform” rating on the stock in a report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating, thirteen have issued a buy rating and two have issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $385.67.

Insider Activity at HCA Healthcare

In related news, SVP Jennifer Berres sold 9,533 shares of the stock in a transaction dated Friday, February 14th. The shares were sold at an average price of $322.59, for a total value of $3,075,250.47. Following the sale, the senior vice president now directly owns 15,412 shares of the company’s stock, valued at $4,971,757.08. This represents a 38.22 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. 1.60% of the stock is owned by insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $329.25 on Monday. HCA Healthcare, Inc. has a twelve month low of $289.98 and a twelve month high of $417.14. The firm has a market cap of $81.06 billion, a P/E ratio of 14.99, a PEG ratio of 1.10 and a beta of 1.68. The company has a 50 day moving average of $321.50 and a 200 day moving average of $342.71. The company has a quick ratio of 0.97, a current ratio of 1.08 and a debt-to-equity ratio of 69.07.

HCA Healthcare (NYSE:HCA) last posted its quarterly earnings data on Friday, January 24th. The company reported $6.22 EPS for the quarter, topping the consensus estimate of $6.03 by $0.19. HCA Healthcare had a return on equity of 586.47% and a net margin of 8.16%. During the same period last year, the business posted $5.90 earnings per share. As a group, research analysts expect that HCA Healthcare, Inc. will post 24.98 EPS for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Monday, March 31st. Shareholders of record on Monday, March 17th will be issued a dividend of $0.72 per share. This represents a $2.88 annualized dividend and a dividend yield of 0.87%. The ex-dividend date of this dividend is Monday, March 17th. This is an increase from HCA Healthcare’s previous quarterly dividend of $0.66. HCA Healthcare’s dividend payout ratio is 13.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.